Replies to post #347033 on Anavex Life Sciences Corp (AVXL)

[georgejjl]

ANAVEX2-73 Study in Pediatric Patients With Rett Syndrome (EXCELLENCE)

ANAVEX2-73-RS-003 is a Phase 2/3, Double-blind, Randomized, Placebo-controlled Safety and Efficacy Study in Pediatric Patients With RTT

https://clinicaltrials.gov/ct2/show/NCT04304482

Top-line data EXCELLENCE: Potentially pivotal Phase 2/3 pediatric RTT clinical trial – expected 1H 2022


Click on the image below:



Good luck and GOD bless,